Search clinical trials for: GTx-024 9mg
Total 14898 results
-
GTxTerminatedMetastatic Breast CancerUnited States
-
GTxWithdrawnER+ and AR+ Breast CancerUnited States
-
GTxWithdrawnStress Urinary IncontinenceUnited States
-
GTxCompletedStress Urinary IncontinenceUnited States
-
GTxCompletedStress Urinary IncontinenceUnited States
-
GTxWithdrawnStress Urinary IncontinenceUnited States
-
GTxCompletedNon-Small Cell Lung Cancer | Muscle WastingUnited States
-
GTxCompletedER+ and AR+ Breast CancerUnited States
-
GTxCompletedNon Small Cell Lung Cancer | Muscle WastingUnited States
-
GTxTerminatedTriple Negative Breast CancerUnited States
-
Palvella Therapeutics, Inc.Active, not recruitingPachyonychia CongenitaUnited States
-
Rubius TherapeuticsTerminatedNon Small Cell Lung Cancer | Head and Neck Squamous Cell Carcinoma | Urothelial Carcinoma | Cutaneous Melanoma | TNBC - Triple-Negative Breast CancerUnited States
-
Asmacure LtéeCompleted
-
Palvella Therapeutics, Inc.UnknownPachyonychia CongenitaUnited States
-
GTxCompletedProstate CancerUnited States
-
GlaxoSmithKlineCompletedAsthmaGermany, South Africa, Bulgaria
-
J2H BiotechCompletedNon-alcoholic SteatohepatitisKorea, Republic of
-
Evaxion Biotech A/SNovotech (Australia) Pty LimitedTerminatedMelanoma Stage IV | Melanoma Stage IIIAustralia
-
Universidade Gama FilhoUnknown
-
Maharishi Markendeswar University (Deemed to be...Not yet recruiting
-
Inmagene LLCRecruiting
-
Nanjing Leads Biolabs Co.,LtdRecruitingAdvanced Solid TumorChina
-
University of North Carolina, Chapel HillNational Institute on Drug Abuse (NIDA); National Institute on Alcohol Abuse... and other collaboratorsCompleted
-
Xencor, Inc.TerminatedRelapsed/ Refractory Multiple MyelomaUnited States, Australia
-
Palvella Therapeutics, Inc.RecruitingPachyonychia CongenitaUnited States
-
Palvella Therapeutics, Inc.RecruitingMicrocystic Lymphatic MalformationUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)CompletedEstrogen Receptor Negative | HER2/Neu Negative | Progesterone Receptor Negative | Metastatic Triple-Negative Breast Carcinoma | Stage IV Breast Cancer AJCC v6 and v7 | Androgen Receptor PositiveUnited States
-
Diwakar DavarTesaro, Inc.RecruitingMelanoma Stage IV | Melanoma Stage IIIUnited States
-
Amicus TherapeuticsActive, not recruiting
-
Asmacure LtéeTerminated
-
Ultragenyx Pharmaceutical IncActive, not recruitingAngelman SyndromeUnited States, United Kingdom, Canada, Australia, France, Germany, Spain, Israel
-
Palvella Therapeutics, Inc.RecruitingBCCs in Gorlin Syndrome PatientsUnited States, United Kingdom
-
Turino, Gerard, M.D.National Heart, Lung, and Blood Institute (NHLBI)CompletedChronic Obstructive Pulmonary Disease (COPD)United States
-
Artax Biopharma IncSimbec ResearchCompleted
-
Asmacure LtéeCompletedMild Allergic AsthmaCanada
-
Helixmith Co., Ltd.Completed
-
Amicus TherapeuticsActive, not recruitingBatten Disease | CLN6United States
-
Kyowa Kirin Co., Ltd.Kyowa Hakko Kirin China Pharmaceutical Co., LTD.Completed
-
BioMarin PharmaceuticalTerminatedDuchenne Muscular DystrophyNetherlands, Belgium, Italy, Sweden
-
PfizerCompletedHepatitis C VirusUnited States
-
University of EdinburghNHS LothianCompleted
-
Artax Biopharma IncSimbec Research; ORION Clinical Services; Packaging Coordinators Inc; Centro de...Completed
-
Travere Therapeutics, Inc.TerminatedPantothenate Kinase-Associated NeurodegenerationUnited States, Canada, Czechia, France, Germany, Italy, Norway, Poland, Spain
-
Foresee Pharmaceuticals Co., Ltd.TerminatedSevere to Critical COVID 19 With Associated ARDSUnited States
-
AmgenCompletedMultiple MyelomaUnited States, Australia
-
Hangzhou Grand Biologic Pharmaceutical, Inc.Peking Union Medical College HospitalUnknownHealthy ParticipantsChina
-
Hutchison Medipharma LimitedTerminatedUlcerative ColitisUnited States